AIP1 in graft arteriosclerosis.

[1]  W. Min,et al.  AIP1 Prevents Graft Arteriosclerosis by Inhibiting Interferon-&ggr;–Dependent Smooth Muscle Cell Proliferation and Intimal Expansion , 2011, Circulation research.

[2]  Gerard Tromp,et al.  Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm , 2010, Nature Genetics.

[3]  Rameen Beroukhim,et al.  An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB , 2010, Nature Medicine.

[4]  Wareef Kabbani,et al.  Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis , 2010, Proceedings of the National Academy of Sciences.

[5]  R. Vessella,et al.  DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis , 2009, Proceedings of the National Academy of Sciences.

[6]  R. Mitchell,et al.  Graft vascular disease: immune response meets the vessel wall. , 2009, Annual review of pathology.

[7]  W. Min,et al.  Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.

[8]  W. Min,et al.  AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. , 2008, The Journal of clinical investigation.

[9]  W. Min,et al.  AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation , 2008, Circulation research.

[10]  J. Li,et al.  Interferon-γ Induces X-linked Inhibitor of Apoptosis-associated Factor-1 and Noxa Expression and Potentiates Human Vascular Smooth Muscle Cell Apoptosis by STAT3 Activation* , 2008, Journal of Biological Chemistry.

[11]  W. Min,et al.  RIP1-mediated AIP1 Phosphorylation at a 14-3-3-binding Site Is Critical for Tumor Necrosis Factor-induced ASK1-JNK/p38 Activation* , 2007, Journal of Biological Chemistry.

[12]  J. Pober,et al.  Interferon-&ggr; Axis in Graft Arteriosclerosis , 2007 .

[13]  S. Litovsky,et al.  Of mice and men: mouse models and the molecular mechanisms of post-transplant coronary artery disease. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  J. Saffitz,et al.  Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart , 2005, Circulation.

[15]  K. Shuai,et al.  Regulation of gene-activation pathways by PIAS proteins in the immune system , 2005, Nature Reviews Immunology.

[16]  M. Thomsen,et al.  Chronic vascular rejection: histologic comparison between two murine experimental models. , 2005, Transplantation proceedings.

[17]  Aseem Kumar,et al.  Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts. , 2005, Biochemical and biophysical research communications.

[18]  Wang Min,et al.  AIP1/DAB2IP, a Novel Member of the Ras-GAP Family, Transduces TRAF2-induced ASK1-JNK Activation* , 2004, Journal of Biological Chemistry.

[19]  Yulan Qing,et al.  Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ* , 2004, Journal of Biological Chemistry.

[20]  William R. Burns,et al.  Interferon‐γ plays a nonredundant role in mediating T‐cell‐ dependent outward vascular remodeling of allogeneic human coronary arteries , 2004 .

[21]  L. V. von Segesser,et al.  Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. , 2003, European heart journal.

[22]  W. Min,et al.  AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. , 2003, The Journal of clinical investigation.

[23]  S. Toyooka,et al.  Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines* 210 , 2003, The Journal of Biological Chemistry.

[24]  G. Stark,et al.  Roles of Phosphatidylinositol 3-Kinase in Interferon-γ-dependent Phosphorylation of STAT1 on Serine 727 and Activation of Gene Expression* , 2001, The Journal of Biological Chemistry.

[25]  P. Libby,et al.  Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.

[26]  J. Darnell,et al.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Hilton,et al.  SOCS: physiological suppressors of cytokine signaling. , 2000, Journal of cell science.

[28]  G. Bondjers,et al.  Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. , 2000, The Journal of biological chemistry.

[29]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[30]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[31]  Richard N. Mitchell,et al.  Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. , 1998, The American journal of pathology.

[32]  M. Russell,et al.  Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. , 1998, The American journal of pathology.

[33]  P. Libby,et al.  Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. , 1997, The Journal of clinical investigation.

[34]  D. Scott,et al.  Why do some females reject males? The molecular basis for male-specific graft rejection , 1997, Journal of Molecular Medicine.

[35]  Vivian Charles McAlister,et al.  Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis. , 1996, Clinical immunology and immunopathology.

[36]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[37]  P. Libby,et al.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. , 1991, The American journal of pathology.

[38]  J. Pober,et al.  Interferon-gamma axis in graft arteriosclerosis. , 2007, Circulation research.

[39]  R. Mitchell,et al.  Allograft arteriopathy: pathogenesis update. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[40]  W. Burns,et al.  Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  W. Min,et al.  AIP 1 mediates TNF-α – induced ASK 1 activation by facilitating dissociation of ASK 1 from its inhibitor 14-3-3 , 2003 .

[42]  J. Pober,et al.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. , 2000, Nature.

[43]  M. Wilhelm,et al.  Chronic rejection. , 1998, Transplantation proceedings.

[44]  Interferon- (cid:1) Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase–Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation , 2022 .